Live feed
Filing
SC 13D
SC 13D0001137439-21-000195·Finch Therapeutics Group, Inc.
Schedule 13D ownership disclosure
Finch Therapeutics Group, Inc.
Security class unavailable
Event date: 2021-03-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,993,057
- Percent of class
- 8.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137439-21-000195
- Form type
- SC 13D
- Filer
- Finch Therapeutics Group, Inc.
- CIK
- CIK 1733257
- Filed
- Mar 29, 2021
- Reporting period
- Mar 19, 2021
- Description
- Schedule 13D beneficial ownership